首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1422996

2024-2032 年子宮內膜異位症市場（按類型、診斷和治療、最終用戶和地區）

Endometriosis Market by Type, Diagnosis and Treatment, End Users, and Region 2024-2032

出版日期: 2024年01月30日 | 出版商:

IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年，全球子宮內膜異位症市場規模達到24億美元。展望未來， IMARC Group預計到2032年市場規模將達到37億美元，2024-2032年複合年成長率（CAGR）為4.71%。由於人們對症狀和診斷的認知不斷提高、各種學名藥的廣泛使用、創新治療方法的發展以及臨床試驗數量的增加，全球市場正在經歷穩定成長。

子宮內膜異位症市場分析：

市場成長與規模：在該病患病率不斷上升、意識不斷提高以及醫療保健基礎設施進步的推動下，全球市場正在經歷強勁成長。隨著越來越多的人尋求子宮內膜異位症的診斷和治療，市場規模不斷擴大，從而促進了對創新治療解決方案和全面醫療保健服務的需求。

主要市場促進因素：主要促進因素包括人們對女性健康問題的認知不斷提高、診斷能力的提高以及研發活動的增加。此外，對以患者為中心的護理的關注和新穎治療方案的引入對市場成長做出了重大貢獻。

技術進步：先進影像技術、微創外科手術和分子診斷等技術進步在塑造治療格局方面發揮關鍵作用。這些創新提高了診斷準確性，改善了手術結果，並為個人化治療方法鋪平了道路。

產業應用：該市場涵蓋廣泛的產業應用，包括製藥、醫療器材和醫療保健服務。製藥公司正在積極開發藥物並將其商業化，而醫療設備製造商則為診斷和外科手術中使用的創新工具和設備做出貢獻。

主要市場趨勢：主要趨勢包括強調早期診斷、加強製藥公司和研究機構之間的合作以及將遠距醫療整合到患者護理中。此外，向整體和以患者為中心的方法的轉變，不僅解決症狀，而且解決疾病的情感和心理方面，正在變得越來越突出。

地理趨勢：地理趨勢揭示了不同地區的市場成長率不同，其中北美由於先進的醫療基礎設施而在市場佔有率方面處於領先地位。在子宮內膜異位症盛行率上升和醫療保健意識提高的推動下，亞太地區正在大幅成長。

競爭格局：競爭格局的特徵是主要參與者透過研究、開發和策略夥伴關係積極為市場成長做出貢獻。市場動態包括老牌製藥公司與將創新推向前沿的新興企業之間的平衡。

挑戰與機會：挑戰包括與延遲診斷、某些地區獲得醫療保健的機會有限以及需要更有效的長期管理方案相關的問題。機會在於研究的進步、全球合作的加強以及解決市場未滿足需求的突破性療法的潛力。

未來展望：市場前景廣闊，預計將持續成長。持續的研究、技術創新和對以患者為中心的護理的關注預計將推動更有效治療方法的開發，進一步加強子宮內膜異位症的整體管理。隨著意識的不斷增強，市場即將成長，為老牌企業和新興企業提供了機會。

子宮內膜異位症市場趨勢：

提高認知和診斷率

推動市場成長的主要因素之一是意識的提高和診斷率的提高。近年來，大眾對子宮內膜異位症的認知顯著提高，子宮內膜異位症是一種類似子宮內膜的組織生長在子宮外的疾病。這種意識的提高導致更多的女性認知並報告症狀，從而促進早期診斷和介入。此外，醫療保健專業人員對這種情況的了解越來越多，從而可以做出更準確、更及時的診斷。因此，對有效治療和管理方案的需求增加，推動了市場的成長。

醫學研究和技術的進步

醫學研究和技術的不斷進步在塑造子宮內膜異位症治療方案方面發揮了至關重要的作用。創新治療方法的發展，包括新藥物、微創手術技術和個人化治療計劃，顯著擴大了患者的選擇範圍。先進的影像技術和生物標記識別等尖端診斷工具有助於更精確、更有效率的診斷。這些進步不僅可以改善患者的治療效果，還可以透過為這種疾病創造一系列新穎且更有效的療法來推動市場成長。

增加女性醫療保健支出和可近性

全球女性人口對女性健康的日益重視和醫療保健支出的增加促進了市場的擴張。隨著社會認知到解決婦女健康問題的重要性，人們更願意分配資源用於與子宮內膜異位症相關的研究、開發和獲得優質醫療保健服務。此外，改善醫療保健設施的可近性，特別是在發展中地區，可確保更大比例的女性能夠就這種疾病尋求醫療護理並接受適當的治療。醫療保健支出的增加和可及性的提高相結合，為子宮內膜異位症領域的研究和患者護理創造了更具支持性的環境，從而推動了市場的成長。

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 10 章：促進因素、限制與機會

概述
促進要素
限制
機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 13 章：價格分析

第14章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- Abbvie Inc.
- Bayer AG
- Debiopharm Group
- Gedeon Richter Plc
- Kissei Pharmaceutical Co. Ltd.
- Myovant Sciences GmbH
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.

簡介目錄圖表

Product Code: SR112024A6676

Abstract

The global endometriosis market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. The global market is experiencing steady growth driven by the rising awareness about symptoms and diagnosis, the widespread availability of various generic drugs, the development of innovative therapeutic approaches, and the increasing number of clinical trials.

Endometriosis Market Analysis:

Market Growth and Size: The global market is experiencing robust growth, driven by an increasing prevalence of the condition, rising awareness, and advancements in healthcare infrastructure. The market size continues to expand as more individuals seek diagnosis and treatment for endometriosis, fostering a demand for innovative therapeutic solutions and comprehensive healthcare services.

Major Market Drivers: Key drivers include the growing awareness of women's health issues, improved diagnostic capabilities, and a rise in research and development activities. Additionally, the focus on patient-centric care and the introduction of novel treatment options contribute significantly to the market growth.

Technological Advancements: Technological advancements, such as advanced imaging techniques, minimally invasive surgical procedures, and molecular diagnostics, play a pivotal role in shaping the landscape of treatment. These innovations enhance diagnostic accuracy, improve surgical outcomes, and pave the way for personalized treatment approaches.

Industry Applications: The market encompasses a wide range of industry applications, including pharmaceuticals, medical devices, and healthcare services. Pharmaceutical companies are actively developing and commercializing medications, while medical device manufacturers contribute with innovative tools and equipment used in diagnostic and surgical procedures.

Key Market Trends: Key trends include the emphasis on early diagnosis, increasing collaborations between pharmaceutical companies and research institutions, and the integration of telemedicine in patient care. Additionally, a shift towards holistic and patient-centered approaches, addressing not only symptoms but also the emotional and psychological aspects of the condition, is gaining prominence.

Geographical Trends: Geographical trends reveal varying rates of market growth across regions, with North America leading in terms of market share due to advanced healthcare infrastructure. The Asia Pacific region is witnessing substantial growth, driven by a rising prevalence of endometriosis and increasing healthcare awareness.

Competitive Landscape: The competitive landscape is characterized by key players actively contributing to the market's growth through research, development, and strategic partnerships. The market dynamics include a balance between established pharmaceutical companies and emerging players bringing innovation to the forefront.

Challenges and Opportunities: Challenges encompass issues related to delayed diagnosis, limited accessibility to healthcare in certain regions, and the need for more effective long-term management options. Opportunities lie in advancements in research, increased global collaboration, and the potential for breakthrough therapies addressing unmet needs in the market.

Future Outlook: The future of the market appears promising, with sustained growth anticipated. Continued research, technological innovations, and a focus on patient-centered care are expected to drive the development of more effective treatments, further enhancing the overall management of endometriosis. As awareness continues to grow, the market is poised for growth, presenting opportunities for both established and emerging players.

Endometriosis Market Trends:

Increased awareness and diagnosis rates

One of the primary factors fueling the growth of the market is the heightened awareness and improved diagnosis rates. In recent years, there has been a significant increase in public awareness regarding endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus. This heightened awareness has led to more women recognizing and reporting symptoms, prompting early diagnosis and intervention. Additionally, healthcare professionals are increasingly knowledgeable about the condition, leading to more accurate and timely diagnoses. As a result, the demand for effective treatments and management options has risen, driving growth in the market.

Advancements in medical research and technology

Ongoing advancements in medical research and technology have played a crucial role in shaping the landscape of endometriosis treatment options. The development of innovative therapeutic approaches, including new medications, minimally invasive surgical techniques, and personalized treatment plans, has significantly expanded the available choices for patients. Cutting-edge diagnostic tools, such as advanced imaging techniques and biomarker identification, contribute to more precise and efficient diagnosis. These advancements not only enhance patient outcomes but also drive market growth by creating a robust pipeline of novel and more effective therapies for this medical disorder.

Increasing female healthcare spending and accessibility

The growing emphasis on women's health and increased healthcare spending among the female population globally has contributed to the expansion of the market. As societies recognize the importance of addressing women's health issues, there is a greater willingness to allocate resources for research, development, and access to quality healthcare services related to endometriosis. Moreover, improved accessibility to healthcare facilities, especially in developing regions, ensures that a larger proportion of women can seek medical attention and receive appropriate treatment for this medical disorder. This combination of increased healthcare spending and enhanced accessibility propels market growth by fostering a more supportive environment for both research and patient care in the field of endometriosis.

Endometriosis Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, diagnosis and treatment, and end users.

Breakup by Type:

Superficial Peritoneal Lesion

Endometrioma

Deeply Infiltrating Endometriosis

Others

The report has provided a detailed breakup and analysis of the market based on the type. This includes superficial peritoneal lesion, endometrioma, deeply infiltrating endometriosis, and others.

Superficial peritoneal lesions are a common type of this disorder, characterized by the presence of endometrial-like tissue on the peritoneum-the thin membrane lining the abdominal cavity. These lesions often cause inflammation, scarring, and pain. Despite being superficial, they can significantly impact a patient's quality of life. Treatment approaches for superficial peritoneal lesions may include pain management, hormonal therapies, or surgical interventions to remove or ablate the lesions.

On the other hand, endometriomas, also known as ovarian cysts or chocolate cysts, occur when endometriotic tissue forms a cyst on the ovaries. These cysts can vary in size and may lead to pelvic pain, infertility, or complications during menstruation. Management of endometriomas often involves a combination of medical and surgical interventions. Surgical options may include cystectomy to remove the cyst while preserving ovarian tissue or oophorectomy in more severe cases. Hormonal treatments are also commonly employed to manage symptoms and prevent recurrence.

Furthermore, deeply infiltrating endometriosis involves the penetration of endometrial-like tissue into the deeper layers of organs within the pelvic cavity, such as the bowel, bladder, or uterosacral ligaments. This form can cause severe pain, organ dysfunction, and fertility issues. Management of deeply infiltrating endometriosis often requires specialized surgical procedures, such as excision surgery, to remove the deeply embedded tissue. Multidisciplinary care, involving gynecologists and other specialists, is crucial for comprehensive management. Hormonal therapies may also be employed to control symptoms and prevent recurrence in cases of deeply infiltrating endometriosis.

Breakup by Diagnosis and Treatment:

Diagnosis

Ultrasound

Pelvic Exam

Laparoscopy

Magnetic Resonance Imaging (MRI)

Hysteroscopy

Sonohysterography

Treatment

Hormonal Therapy

Pain Management

Conservative Surgery

A detailed breakup and analysis of the market based on the diagnosis and treatment have also been provided in the report. This includes diagnosis (ultrasound, pelvic exam, laparoscopy, magnetic resonance imaging (MRI), hysteroscopy, and sonohysterography) and treatment (hormonal therapy, pain management, and conservative surgery).

The diagnosis involves a multi-faceted approach, combining clinical evaluation, imaging studies, and, in some cases, surgical procedures. Clinicians rely on a detailed medical history, including the description of symptoms such as pelvic pain, dysmenorrhea, and infertility. Physical examinations, including pelvic exams, may provide additional insights. Imaging techniques, such as transvaginal ultrasound or magnetic resonance imaging (MRI), aid in visualizing endometrial lesions and assessing their extent. Definitive diagnosis often requires laparoscopic surgery, allowing direct visualization and biopsy of endometriotic tissue.

On the other hand, the management of this disorder is tailored to individual patient needs and may involve a combination of medical, surgical, and supportive interventions. Hormonal therapies, including birth control pills, progestins, or GnRH agonists, are commonly employed to control symptoms by suppressing estrogen production. Non-steroidal anti-inflammatory drugs (NSAIDs) may be used for pain relief. In cases where fertility is a concern, assisted reproductive technologies (ART) or fertility-preserving surgeries may be considered. Surgical interventions, such as laparoscopic excision or ablation of endometrial lesions, aim to alleviate symptoms and improve fertility. In severe cases, particularly with deeply infiltrating endometriosis, more extensive surgeries may be necessary, involving excision of affected organs or tissues. Multidisciplinary care, involving gynecologists, fertility specialists, and pain management experts, is crucial for comprehensive treatment.

Breakup by End Users:

Hospitals

Homecare

Speciality Centers

Others

Hospitals represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end users. This includes hospitals, homecare, speciality centers, and others According to the report, hospitals represented the largest segment.

Hospitals serve as critical end-users in the market, playing a central role in diagnosis, treatment, and management of the condition. These institutions provide comprehensive care, including surgical interventions, medication administration, and post-operative monitoring. The collaborative nature of hospital settings facilitates the coordination of multidisciplinary teams, comprising gynecologists, surgeons, and other specialists, ensuring a holistic approach to the medical disi care. Moreover, hospitals often serve as hubs for medical research and innovation, actively contributing to the development of advanced treatment modalities and enhancing the overall landscape of this disorder management.

On the contrary, homecare represents an increasingly important segment in patient care, offering personalized and convenient solutions for individuals managing the chronic nature of the condition. Home-based care involves the administration of medications, pain management strategies, and monitoring of symptoms in the familiar and comfortable environment of patients' homes. This segment has witnessed growth with the advent of telemedicine, allowing healthcare professionals to remotely engage with patients, provide consultations, and monitor treatment adherence. Homecare not only enhances patient comfort but also contributes to cost-effective and efficient healthcare delivery, aligning with the trend toward patient-centric care models in the market.

Moreover, specialty centers dedicated to women's health and gynecological care have emerged as specialized end-users in the market. These centers focus on delivering targeted and specialized services for disorder diagnosis, treatment, and support. With a dedicated focus on gynecological conditions, these centers often house experts in the field, ensuring a high level of expertise and personalized care for patients with endometriosis. The establishment of these centers contributes to streamlined and efficient care pathways, fostering an environment that prioritizes the unique needs of individuals affected by endometriosis. Additionally, specialty centers frequently serve as hubs for clinical trials and research, driving advancements in the understanding and management of this medical disorder.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest endometriosis market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has consistently held a prominent position as the largest market, driven by factors such as advanced healthcare infrastructure, high awareness levels, and a significant focus on women's health. The region benefits from robust research and development activities, leading to the continuous introduction of innovative treatment options. Additionally, increasing awareness campaigns and advocacy efforts contribute to early detection and treatment. The prevalence of endometriosis cases and a well-established healthcare system with access to cutting-edge technologies further solidify North America's dominance in the global market.

The Asia Pacific region is witnessing substantial growth in the market, propelled by a rising prevalence of the condition, improving healthcare infrastructure, and increased awareness. As societies in the region become more attuned to women's health issues, there is a growing emphasis on early diagnosis and effective management of endometriosis. Pharmaceutical companies are expanding their presence in the Asia Pacific, introducing novel therapies and leveraging partnerships to address the changing healthcare needs of the population. Moreover, cultural shifts and changing demographics contribute to a greater focus on women's health in the region, fostering a conducive environment for market expansion.

Europe stands as a significant market, characterized by a high prevalence of the condition and a well-established healthcare system. The region benefits from extensive research initiatives, leading to the development of advanced treatment options. European countries prioritize women's health, and initiatives for early detection and management of endometriosis contribute to market growth. Collaboration between pharmaceutical companies and research institutions enhances the region's capabilities in driving innovations. The European market for endometriosis is characterized by a comprehensive approach to patient care, with a focus on both medical interventions and supportive services.

Latin America is experiencing a growing awareness of the disorder, leading to an expanding market for treatment options. The region grapples with challenges such as limited access to healthcare in certain areas, but initiatives aimed at improving healthcare infrastructure contribute to addressing these issues. Rising advocacy for women's health and increasing efforts to reduce the diagnostic and treatment gap are driving market growth in Latin America. Pharmaceutical companies are exploring opportunities in this region, introducing therapies and collaborating with local healthcare providers to enhance accessibility to endometriosis care.

The Middle East and Africa are emerging markets, marked by a gradual increase in awareness and healthcare infrastructure development. While the prevalence of this disorder is gaining recognition, the region faces challenges related to societal stigmas and limited healthcare resources in certain areas. However, ongoing efforts to address women's health issues and improve healthcare accessibility contribute to the market's growth. Pharmaceutical companies are increasingly exploring partnerships and market entry strategies to tap into the potential of this region, aiming to provide effective solutions for individuals affected by this disorder.

Leading Key Players in the Endometriosis Industry:

The key players in the market are driving growth through strategic initiatives, research and development, and market expansion. Pharmaceutical companies invest heavily in developing and commercializing innovative therapies for endometriosis. These companies leverage their expertise to create advanced medications that address the specific needs of patients, improving treatment outcomes. Collaborations and partnerships with research institutions further enhance their capabilities in understanding the disease and developing breakthrough solutions. Additionally, key players focus on expanding their market presence through geographical expansion and acquisitions. By entering emerging markets and acquiring smaller companies with promising pipelines, these players secure a competitive edge. Furthermore, they engage in educational initiatives and awareness campaigns, aiming to increase understanding of endometriosis among healthcare professionals and the general public, ultimately driving demand for their products and contributing to the overall growth of the market.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

AbbVie Inc.

Bayer AG

Debiopharm Group

Gedeon Richter Plc

Kissei Pharmaceutical Co. Ltd.

Myovant Sciences GmbH

Sanofi S.A.

Teva Pharmaceutical Industries Ltd.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

January 8, 2024: Abbott and Tandem Diabetes Care, Inc. have jointly revealed the t:slim X2 insulin pump, equipped with Control-IQ technology has become the inaugural automated insulin delivery (AID) system to seamlessly integrate with Abbott's recently launched FreeStyle Libre 2 Plus sensor. This sensor represents Abbott's latest advancement in continuous glucose monitoring (CGM) technology, marking a collaborative effort to enhance the capabilities of insulin delivery systems and continuous glucose monitoring for individuals managing diabetes.

January 9, 2024: AbbVie introduced PRODUODOPA (foslevodopa/foscarbidopa) in the European Union. This medication is designed to address advanced Parkinson's disease accompanied by severe motor fluctuations, hyperkinesia (excessive movement), or dyskinesia (involuntary movement). PRODUODOPA is specifically intended for situations where combinations of existing Parkinson's medicinal products have not yielded satisfactory results.

January 8, 2024: Bayer announced the expansion of the clinical development program for the investigational compound elinzanetant.

Key Questions Answered in This Report:

How has the global endometriosis market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global endometriosis market?
What is the impact of each driver, restraint, and opportunity on the global endometriosis market?
What are the key regional markets?
Which countries represent the most attractive endometriosis market?
What is the breakup of the market based on the type?
Which is the most attractive type in the endometriosis market?
What is the breakup of the market based on the diagnosis and treatment?
Which is the most attractive diagnosis and treatment in the endometriosis market?
What is the breakup of the market based on the end users?
Which is the most attractive end users in the endometriosis market?
What is the competitive structure of the market?
Who are the key players/companies in the global endometriosis market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Endometriosis Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Superficial Peritoneal Lesion
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Endometrioma
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Deeply Infiltrating Endometriosis
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Diagnosis & Treatment

7.1 Diagnosis
- 7.1.1 Market Trends
- 7.1.2 Key Segments
  - 7.1.2.1 Ultrasound
  - 7.1.2.2 Pelvic Exam
  - 7.1.2.3 Laparoscopy
  - 7.1.2.4 Magnetic Resonance Imaging (MRI)
  - 7.1.2.5 Hysteroscopy
  - 7.1.2.6 Sonohysterography
- 7.1.3 Market Forecast
7.2 Treatment
- 7.2.1 Market Trends
- 7.2.2 Key Segments
  - 7.2.2.1 Hormonal Therapy
  - 7.2.2.2 Pain Management
  - 7.2.2.3 Conservative Surgery
- 7.2.3 Market Forecast

8 Market Breakup by End Users

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Homecare
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Speciality Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Abbvie Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Bayer AG
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Debiopharm Group
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Gedeon Richter Plc
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Kissei Pharmaceutical Co. Ltd.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Myovant Sciences GmbH
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Sanofi S.A.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Teva Pharmaceutical Industries Ltd.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

簡介目錄圖表

List of Figures

Figure 1: Global: Endometriosis Market: Major Drivers and Challenges
Figure 2: Global: Endometriosis Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Endometriosis Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Endometriosis Market: Breakup by Type (in %), 2023
Figure 5: Global: Endometriosis Market: Breakup by Diagnosis & Treatment (in %), 2023
Figure 6: Global: Endometriosis Market: Breakup by End Users (in %), 2023
Figure 7: Global: Endometriosis Market: Breakup by Region (in %), 2023
Figure 8: Global: Endometriosis (Superficial Peritoneal Lesion) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Endometriosis (Superficial Peritoneal Lesion) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Endometriosis (Endometrioma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Endometriosis (Endometrioma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Endometriosis (Deeply Infiltrating Endometriosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Endometriosis (Deeply Infiltrating Endometriosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Endometriosis (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Endometriosis (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Endometriosis (Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Endometriosis (Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Endometriosis (Treatment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Endometriosis (Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Endometriosis (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Endometriosis (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Endometriosis (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Endometriosis (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Endometriosis (Speciality Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Endometriosis (Speciality Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Endometriosis (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Endometriosis (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: North America: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: North America: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: United States: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: United States: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Canada: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Canada: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Asia-Pacific: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Asia-Pacific: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: China: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: China: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Japan: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Japan: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: India: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: India: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: South Korea: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: South Korea: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Australia: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Australia: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Indonesia: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Indonesia: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Others: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Others: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Europe: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Europe: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Germany: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Germany: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: France: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: France: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: United Kingdom: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: United Kingdom: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Italy: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Italy: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Spain: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Spain: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Russia: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Russia: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Latin America: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Latin America: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Brazil: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Brazil: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Mexico: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Mexico: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Middle East and Africa: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Middle East and Africa: Endometriosis Market: Breakup by Country (in %), 2023
Figure 76: Middle East and Africa: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Global: Endometriosis Industry: Drivers, Restraints, and Opportunities
Figure 78: Global: Endometriosis Industry: Value Chain Analysis
Figure 79: Global: Endometriosis Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Endometriosis Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Endometriosis Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Endometriosis Market Forecast: Breakup by Diagnosis & Treatment (in Million US$), 2024-2032
Table 4: Global: Endometriosis Market Forecast: Breakup by End Users (in Million US$), 2024-2032
Table 5: Global: Endometriosis Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Endometriosis Market: Competitive Structure
Table 7: Global: Endometriosis Market: Key Players

02-2729-4219

+886-2-2729-4219